Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Citi
McKinsey
Chubb
US Army
Farmers Insurance
Novartis
Dow
Healthtrust

Generated: August 23, 2017

DrugPatentWatch Database Preview

ENTECAVIR Drug Profile

« Back to Dashboard

What is the patent landscape for Entecavir, and when can generic versions of Entecavir launch?

Entecavir is a drug marketed by Aurobindo Pharma Ltd, Teva Pharms Usa, Hetero Labs Ltd V, Zydus Pharms Usa Inc, Amneal Pharms, Cipla Ltd, Sandoz Inc, and Par Pharm Inc. and is included in eight NDAs.

The generic ingredient in ENTECAVIR is entecavir. There are fifteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the entecavir profile page.

Summary for Tradename: ENTECAVIR

Patents:0
Applicants:8
NDAs:8
Suppliers / Packagers: see list13
Bulk Api Vendors: see list64
Clinical Trials: see list157
Patent Applications: see list1,632
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ENTECAVIR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
ENTECAVIR
entecavir
TABLET;ORAL206217-001Aug 26, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
ENTECAVIR
entecavir
TABLET;ORAL206745-001Jun 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ENTECAVIR
entecavir
TABLET;ORAL202122-002Aug 26, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla Ltd
ENTECAVIR
entecavir
TABLET;ORAL206872-002Dec 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
ENTECAVIR
entecavir
TABLET;ORAL206745-002Jun 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Teva
Moodys
QuintilesIMS
Cipla
Colorcon
McKesson
Citi
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot